Levy Jared, Keidar Andrei, Eldar Shai Meron, Abu Abeid Adam
The Faculty of Medical and Health Sciences, Tel Aviv University, Israel.
The Faculty of Medical and Health Sciences, Tel Aviv University, Israel; Division of General Surgery, Tel Aviv Sourasky Medical Center, The Faculty of Medical and Health Sciences, Tel Aviv University, Israel.
Int J Surg Case Rep. 2025 Jul 4;134:111601. doi: 10.1016/j.ijscr.2025.111601.
Cholelithiasis is common following metabolic and bariatric surgery (MBS), with gallstones developing in up to one-third of patients due to rapid weight loss and metabolic changes. Procedures such as Roux-en-Y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB) alter gastrointestinal anatomy, complicating endoscopic access to the biliary tree and presenting challenges in the management of choledocholithiasis. This report highlights the relationship between MBS and biliary complications, using a case of post-OAGB cholangitis due to a retained stent to illustrate broader management considerations.
A 50-year-old female with a history of vertical banded gastroplasty, laparoscopic cholecystectomy, and prior ERCP with CBD stent placement for choledocholithiasis underwent OAGB. One month postoperatively, she had abdominal pain and fever. An abdominal CT scan showed a retained stent in the CBD. Due to altered anatomy after OAGB, standard endoscopic stent retrieval was not feasible. She underwent laparoscopic CBD exploration with intraoperative ultrasound to identify the retained stent. A longitudinal choledochotomy was performed, the stent and stone debris were removed, and the choledochotomy was closed primarily. Her postoperative course was uneventful.
In patients after OAGB, standard biliary access is not feasible, and alternative approaches are required. Laparoscopic CBD exploration is one option that was shown to be effective in this case.
This case highlights the challenge of managing biliary disease in post-MBS patients. A detailed history and file review help prevent stent retention. Laparoscopic CBD exploration offers a safe and effective solution when conventional endoscopic access is limited.
胆石症在代谢和减重手术后很常见,由于体重快速下降和代谢变化,多达三分之一的患者会形成胆结石。诸如Roux-en-Y胃旁路术(RYGB)和单吻合口胃旁路术(OAGB)等手术会改变胃肠道解剖结构,使内镜进入胆道系统变得复杂,并给胆总管结石的管理带来挑战。本报告通过一例因支架残留导致的OAGB术后胆管炎病例,强调了代谢和减重手术与胆道并发症之间的关系,以说明更广泛的管理考虑因素。
一名50岁女性,有垂直束带胃成形术、腹腔镜胆囊切除术病史,既往因胆总管结石行内镜逆行胰胆管造影术(ERCP)并放置胆总管支架,接受了OAGB手术。术后1个月,她出现腹痛和发热。腹部CT扫描显示胆总管内有一个残留支架。由于OAGB术后解剖结构改变,标准的内镜下支架取出术不可行。她接受了腹腔镜胆总管探查术,并术中使用超声来识别残留支架。进行了胆总管纵行切开术,取出了支架和结石碎片,然后将胆总管切开处一期缝合。她的术后病程顺利。
对于OAGB术后的患者,标准的胆道通路不可行,需要采用替代方法。腹腔镜胆总管探查术是一种选择,在本病例中显示有效。
本病例突出了代谢和减重手术后患者胆道疾病管理的挑战。详细的病史和病历审查有助于预防支架残留。当传统内镜通路受限,腹腔镜胆总管探查术提供了一种安全有效的解决方案。